[Skip to Navigation]
Research Letter
December 11, 2023

Change in Epidemiology of Creutzfeldt-Jakob Disease in the US, 2007-2020

Author Affiliations
  • 1Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 2Department of Economics, Stanford University, Stanford, California
  • 3Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • 4Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, California
  • 5Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland
JAMA Neurol. 2024;81(2):195-197. doi:10.1001/jamaneurol.2023.4678

Creutzfeldt-Jakob disease (CJD) is a rapidly progressive and universally fatal prion disease.1 Research on CJD in the US showed stable incidence from 1979 to 2006, though recent trends are not as well described.2 The incidence of sporadic CJD, the most common type, is higher among older patients.1,2 Due to aging populations worldwide, the epidemiology of CJD is evolving.3 We examined death certificate data from 2007 to 2020 to better understand recent US trends of CJD.

Add or change institution
×